Improvement in Patient‐Reported Emotional Symptoms and Activity Limitations due to Hair Loss in Patients With Alopecia Areata Treated With Ritlecitinib: Additional Analyses From ALLEGRO ‐2b/3

Documenti analoghi

• The Financial and Time Burden of Alopecia Areata
  di: Samantha Gregoire, et al.
  Pubblicazione: (2025)
• Efficacy and Safety of Ritlecitinib in the Asian Subpopulation of the ALLEGRO ‐2b/3 and ALLEGRO ‐ LT Clinical Studies for Alopecia Areata
  di: Rie Ueki, et al.
  Pubblicazione: (2026)
• Beyond Hair Regrowth: Interpreting the Psychosocial Impact of Ritlecitinib in Alopecia Areata
  di: Bangdi Chen, et al.
  Pubblicazione: (2026)
• Perceived Stigma Among Adults With Alopecia Areata in the United States
  di: Genevieve Gauthier, et al.
  Pubblicazione: (2025)
• COLLAB: A Global Survey of Clinical and Laboratory Assessment in Alopecia Areata by Hair Specialists
  di: Cathal O'Connor, et al.
  Pubblicazione: (2025)